Biomarker Targeted Stimulation for Epileptiform Events

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

September 1, 2029

Conditions
Epilepsy
Interventions
DEVICE

Biomarker Targeted Stimulation (BTS)

Using continuous stimulation to target multiple network nodes, Biomarker Targeted Stimulation (BTS) is intended to suppress abnormal interictal activity, as determined by biomarkers including interictal epileptiform discharges (IED) and high frequency oscillations (HFO), with the intention to reduce brain hyperexcitability, thereby limiting seizure occurrence.

Sponsors
All Listed Sponsors
lead

Cadence Neuroscience

INDUSTRY

NCT06424977 - Biomarker Targeted Stimulation for Epileptiform Events | Biotech Hunter | Biotech Hunter